The necessity of targeted and controlled drug delivery systems to increase the therapeutic efficiency and safety profile of medications, need for efficient biologics delivery systems, requirement of novel DDS for satisfying the therapeutic variations of elderly and pediatric population, increasing R&D exp...
-
How fast the market of your interest is growing?
Key drivers behind the growth..
-
What are your biggest Challenges?Identify the key problems.. -
What are your Revenue pockets?Areas you need to bet.. -
What are your Competitors doing?Know your competitive edge.. -
Who is your Customer?Get Their changing preferences..
what we offer
Report Store
Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.
IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.
IQ4I
Latest Reports
Factors like high cost of drug delivery technology integrated products, concerns about the adverse effects associated with drug delivery systems, the inconsistent and evolving global drug delivery systems regulatory landscape, emergence of several therapeutic medical devices and advanced drug delivery devices and inefficiency of toxicity testing and evaluation studies in characterizing the novel drug delivery formulations are hampering the market growth.
Increasing incidence of heart failure, shortage of heart donors, technological advancements are some of the driving factors of the market
The global rise in the prevalence and incidence of diabetes, increasing demand for less minimally invasive or non-invasive and point-of-care devices, increasing R&D investments are driving the market growth.
therapeutics, patent expiration of small molecules, advanced technologies in API and FDF manufacturing, increasing deals and investments, increased demand for generic injectable, increasing incidence and prevalence of chronic diseases, and increase in geriatric population are some of the factors driving the market growth.
IQ4I Research & Consultancy published a new report on - Drug Discovery Outsourcing (DDO) Global Market - Forecast To 2030 analyzes and studies the major competition, market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World.
Adoption of biologics in disease management and increasing regulatory approvals in the last few years, increasing scope of HPAPI market, patent expiration of major drugs, increasing trend of outsourcing, increase in the prevalence of chronic diseases, and increase in geriatric population are some of the factors driving the market growth.
The increase in diagnostic imaging procedures and interventional imaging procedures, increase in incidence and prevalence of disease conditions, increasing in aging population, expansion in indications of contrast media, growth of medical imaging technologies in the emerging market, increasing research activities for contrast agents, and favorable reimbursements are driving the market growth
Factors like emergence of technologically advanced stent products, persistently escalating geriatric population and the feasibility of even drug eluting stents (DES) in them and the numerous acquisitions and distribution agreements among the stent companies are further substantiating enormous growth opportunities of the market.
An increase in the adoption of minimally invasive surgeries, rapid growth in the aging population, growing number of cosmetic surgeries, the prevalence of obesity and its related surgeries, the advancement in technology, and demand for electrosurgical procedures in emerging regions are driving the growth.
Some of the factors driving the market are increase in incidence and prevalence of osteoporosis, osteoarthritis, degenerative disc disease, herniated disc, scoliosis, kyphosis, lordosis, Ankylosing spondylitis, sacroiliac joint dysfunction, and, sports injuries, trauma, or abnormal anatomical developments leading to chronic disability and increase in the aging population, technological advancement, and acquisitions.
IQ4I
Latest News
Factors such as rising geriatric population, vast pipeline of products and increasing in funding are providing opportunities for growth....
IQ4I
Clientele
Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).
